Original Article

Mesalazine in the treatment of extensive alopecia areata: A new therapeutic option?

Ana Elisa Kiszewski, Mariele Bevilaqua, Luciana Boff De Abreu

Background: Alopecia areata (AA) is a T-lymphocyte-mediated disease that results in alopecia plaques or diffuses alopecia on the scalp and body. Etiologic factors include genetic and autoimmu...

[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Original Article

Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients

Chandrashekar Byalekere Shivanna, Chaithra Shenoy, R Arti Priya

Background: Alopecia areata (AA) is a chronic autoimmune disorder characterized by patchy loss of hair from scalp, beard, eyebrows, or rarely even body hair. Rarely, the disease can be widesp...

[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Original Article

Minoxidil downregulates Interleukin-1 alpha gene expression in HaCaT cells

Erkin Pekmezci, Murat Turkoğlu, Hilal Gökalp, Zekayi Kutlubay

Introduction: Minoxidil has been used topically to stimulate hair growth for male androgenetic alopecia (AGA) for more than 3 decades. It is currently being used for female AGA and alopecia a...

[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Read more....

Scientific Abstracts

15th Annual Meeting of the European Hair Research Society on July 6-9, 2011,
Jerusalem, Israel

Click here to View